Tackling Big Challenges Together

Dementia Network Calgary takes a collective impact approach to achieving its strategic priorities.
Our Approach
Collective impact emerged in the early 2000s as an approach to addressing complex social challenges that could not effectively be addressed by any one organization.
Kania and Kramer define collective impact as “the commitment of a group of important actors from different sectors to a common agenda for solving a specific social problem”. According to FSG, the consulting firm co-founded by Kramer and managed by Kania, the five conditions of collective impact success are:
1
Common Agenda
2
Shared Measurement
3
Mutually Reinforcing Activities
4
Continuous Communication
5
Backbone Support
Knowledge Hub: Strategies & Solutions
Explore professional resources, reports, and research about dementia; learn more about systems change and collective impact approaches.
This roadmap was developed by Dr. Seema King, Dr. Jessica Simon, Dr Jayna Holroyd-Leduc from their research into support needed by dementia caregivers in Alberta at key points in their person's dementia journey. The map was designed by Sam Hester as a way to visually represent information and helpful resources to consider at different stages, such as getting a diagnosis, driving, making day-to-day decisions, deciding on care options, and self-care.
This roadmap was developed by Dr. Seema King, Dr. Jessica Simon, Dr Jayna Holroyd-Leduc from their research into support needed by dementia caregivers in Alberta at key points in their person's dementia journey. The map was designed by Sam Hester as a way to visually represent information and helpful resources to consider at different stages, such as getting a diagnosis, driving, making day-to-day decisions, deciding on care options, and self-care.
The USA's Food and Drug Administration has approved the first blood test for diagnosing Alzheimer's disease, developed by Japan-based Fujirebio Diagnostics.
The USA's Food and Drug Administration has approved the first blood test for diagnosing Alzheimer's disease, developed by Japan-based Fujirebio Diagnostics.
This podcast episode from the Collective Impact Forum discusses the importance of policy and advocacy work to the success of collective impact initiatives like the Dementia Network
This podcast episode from the Collective Impact Forum discusses the importance of policy and advocacy work to the success of collective impact initiatives like the Dementia Network